Back to Top

To access this information, you must confirm, by pressing on the button marked “I Confirm”, that at the time of access, you are located in India. If you cannot make this confirmation, you must press the button marked “I Do Not Confirm”.

The documentation contained in these pages is posted solely to comply with Indian legal and regulatory requirements. Making the information contained herein available in electronic format does not constitute an offer to sell, the solicitation of an offer to buy, or a recommendation to buy or sell securities of the Company in the United States or in any other jurisdiction, including without limitation, India.

Press Release

Sagility Reports Strong Q3 FY2026 Performance with 35.7% Revenue Growth

Adjusted EBITDA margin reaches 26.0% and Adjusted PAT rises 23.0% year over year

BENGALURU, INDIA – January 28, 2026 Sagility Limited (NSE: SAGILITY, BSE: 544282), a leading global provider of technology-enabled business solutions and services to clients in the U.S. health care industry, reported its consolidated financial results for the quarter ended December 31, 2025, in accordance with Indian Accounting Standards (IndAS). 

Financial Highlights — Quarter Ended December 31, 2025

  • Revenue: ₹19,712 million (US$222.0 million), up 35.7% year over year (29.1% constant currency) 
  • Organic growth: 19.9% (13.9% constant currency) 
  • Adjusted EBITDA: ₹5,125 million (US$57.7 million), 26.0% of revenue, up 24.2% 
  • Adjusted PAT: ₹3,229 million (US$36.4 million), 16.4% of revenue, up 23.0% 
  • Basic EPS: ₹0.57, up 23.9% 
  • Adjusted Basic EPS: ₹0.69, up 23.0% 

Financial Highlights — Nine Months Ended December 31, 2025

  • Revenue: ₹51,686 million (US$591.8 million), up 29.2% year over year (24.2% constant currency) 
  • Organic growth: 18.0% (13.5% constant currency) 
  • Adjusted EBITDA: ₹13,164 million (US$150.7 million), 25.5% of revenue, up 25.3% 
  • Adjusted PAT: ₹8,236 million (US$94.3 million), 15.9% of revenue, up 44.3% 
  • Basic EPS: ₹1.42, up 82.7% 
  • Adjusted Basic EPS: ₹1.76, up 41.7% 

Additional Business Updates

  • Workforce totaled 48,522 employees at the end of Q3 
  • Presence in five countries with 35 delivery centers 
  • Recognized as an Innovator in RCM Business Process Transformation in Avasant’s RadarView™ 2025 
  • Named among India’s Best Workplaces in Pharmaceuticals, Healthcare and Biotech 2025 
  • Earned the EcoVadis Committed Badge for sustainability performance 

Leadership Commentary

Ramesh Gopalan, Managing Director and Group CEO, said the company’s quarterly performance built on strong first-half momentum, noting that open enrollment outcomes were particularly strong across large payer relationships. He added that the BroadPath acquisition expanded Sagility’s exposure to open-enrollment-driven work and broadened its payer client base, supported by disciplined execution. He also noted that client engagements are increasingly structured around outcome-based delivery models emphasizing efficiency and cost reduction, positioning the company well for sustained performance. 

Abhishek Kayan, Deputy Chief Financial Officer, said the quarter demonstrated Sagility’s ability to scale rapidly while maintaining financial discipline, supported by strong cost management and operational execution. He added that the company continues reducing debt, maintaining balance sheet strength and investing selectively in AI, domain capabilities and workforce development to sustain growth and margins. 

About Sagility Limited

Sagility is a technology-enabled, health care-focused solutions and services provider supporting U.S.-based payers, providers and their partners in delivering high-quality operations, improving member and provider experiences and achieving cost-effective clinical and financial outcomes. With more than two decades of experience, Sagility combines deep domain expertise with advanced technology, processes and solutions to address complex industry challenges. The company serves seven of the top U.S. health insurance companies and operates delivery centers across India, the Philippines, the United States, Jamaica and Colombia. 

Safe Harbor Statement

Certain statements in this release concerning future growth prospects are forward-looking statements that involve risks and uncertainties that could cause actual results to differ materially. The company undertakes no obligation to update such statements publicly. 

Investor Relations Contact
Abhishek Kayan: abhishek.kayan@sagility.com

Media Contact
Dhaivat Mehta: dhaivat.mehta@sagility.com

Email Address: mediarelations@sagilityhealth.com

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful. Privacy Policy